Methods for treating metastatic triple negative breast cancer with anti-pd-1 antibodies
US-2022380469-A1 · Dec 1, 2022 · US
This page is not indexed by search engines while we improve data quality.
Guo Zifang patents
Guo Zifang is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Guo Zifang |
| Total patents | 4 |
| First publication | Aug 23, 2018 |
| Latest publication | Dec 1, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Genetic markers associated with response to crth2 receptor antagonists
US-2021348235-A1 · Nov 11, 2021 · US
Genetic markers associated with response to CRTH2 receptor antagonists
US-11091806-B2 · Aug 17, 2021 · US
Genetic markers associated with response to crth2 receptor antagonists
US-2018237856-A1 · Aug 23, 2018 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Sharp & Dohme | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P11/06 | 3 |
| A61K31/437 | 3 |
| C12Q2600/106 | 3 |
| A61K31/4192 | 3 |
| A61K31/47 | 3 |